Joseph del Moral

Field Trip Discovery and Field Trip Health have been reorganized into two separate companies. The Discovery division has been renamed Reunion Neuroscience Inc. and may be found on NASDAQ and CSE as “REUN”, while Field Trip Health is now Field Trip Health & Wellness Ltd. (Field Trip...

Developer and provider of psychedelic therapies Field Trip Health Ltd. has announced the first successful dosing of a Phase 1 clinical trial on it's proprietary psychedelic molecule. The Phase 1 trial is a double-blind, randomized, placebo-controlled study investigating the safety,...

Field Trip Health Ltd. (NASDAQ: FTRP), a biotech and care delivery company in the psychedelics space, has been granted its first patent by the U.S. Patent and Trademark Office. The patent covers claims around FT-104, the company’s flagship proprietary psychedelic molecule, for composition of...

Field Trip Health (OTCQX: FTRPF) announced Wednesday the closing of a CA$95 million ($76.5 million) offering. The raise is one of the largest in the sector’s history, and puts Field Trip’s cash on hand at roughly CA$113.7 million ($91.5 million).  Proceeds are expected to be used...